These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16763372

  • 1. Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
    Haim M, Tanne D, Goldbourt U, Doolman R, Boyko V, Brunner D, Sela BA, Behar S.
    Cardiology; 2007; 107(1):52-6. PubMed ID: 16763372
    [Abstract] [Full Text] [Related]

  • 2. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M, Benderly M, Tanne D, Matas Z, Boyko V, Fisman EZ, Tenenbaum A, Zimmlichman R, Battler A, Goldbourt U, Behar S.
    Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
    [Abstract] [Full Text] [Related]

  • 3. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
    Tanne D, Haim M, Goldbourt U, Boyko V, Reshef T, Adler Y, Benderly M, Mekori YA, Behar S.
    Int J Cardiol; 2006 Mar 08; 107(3):322-6. PubMed ID: 16503253
    [Abstract] [Full Text] [Related]

  • 4. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
    Brodov Y, Behar S, Boyko V, Chouraqui P.
    Am J Cardiol; 2010 Dec 15; 106(12):1717-20. PubMed ID: 21126615
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study.
    Haim M, Boyko V, Goldbourt U, Battler A, Behar S.
    Arch Intern Med; 2004 Feb 23; 164(4):433-9. PubMed ID: 14980995
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.
    Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA.
    Stroke; 2003 Mar 23; 34(3):632-6. PubMed ID: 12624283
    [Abstract] [Full Text] [Related]

  • 7. Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction.
    Matetzky S, Freimark D, Ben-Ami S, Goldenberg I, Leor J, Doolman R, Novikov I, Eldar M, Hod H.
    Arch Intern Med; 2003 Sep 08; 163(16):1933-7. PubMed ID: 12963566
    [Abstract] [Full Text] [Related]

  • 8. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 9. Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.
    Leowattana W, Mahanonda N, Bhuripunyo K, Pokum S.
    J Med Assoc Thai; 2000 May 01; 83(5):536-42. PubMed ID: 10863900
    [Abstract] [Full Text] [Related]

  • 10. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study.
    Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Leor J, Mekori YA, Behar S.
    J Am Coll Cardiol; 2002 Apr 03; 39(7):1133-8. PubMed ID: 11923036
    [Abstract] [Full Text] [Related]

  • 11. Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudy.
    Haim M, Benderly M, Boyko V, Goldenberg I, Tanne D, Battler A, Goldbourt U, Behar S, Bezafibrate Infarction Prevention (BIP) Study Group.
    Coron Artery Dis; 2006 Aug 03; 17(5):455-61. PubMed ID: 16845254
    [Abstract] [Full Text] [Related]

  • 12. [Homocysteine and coronary events in coronary disease patients].
    Ambrosi P, Barlatier A, Artaud-Navarro A, Habib G, Ferracci A, Boussuges A, Garçon D, Bouvenot G, Luccioni R.
    Ann Cardiol Angeiol (Paris); 1999 Mar 03; 48(3):185-9. PubMed ID: 12555379
    [Abstract] [Full Text] [Related]

  • 13. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg.
    Zylberstein DE, Bengtsson C, Björkelund C, Landaas S, Sundh V, Thelle D, Lissner L.
    Circulation; 2004 Feb 10; 109(5):601-6. PubMed ID: 14769681
    [Abstract] [Full Text] [Related]

  • 14. Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention trial).
    Goldenberg I, Goldbourt U, Boyko V, Behar S, Reicher-Reiss H, BIP Study Group.
    Am J Cardiol; 2006 Feb 15; 97(4):466-71. PubMed ID: 16461038
    [Abstract] [Full Text] [Related]

  • 15. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study.
    Arcavi L, Behar S, Caspi A, Reshef N, Boyko V, Knobler H.
    Am Heart J; 2004 Feb 15; 147(2):239-45. PubMed ID: 14760320
    [Abstract] [Full Text] [Related]

  • 16. Serum total homocysteine and coronary heart disease: prospective study in middle aged men.
    Whincup PH, Refsum H, Perry IJ, Morris R, Walker M, Lennon L, Thomson A, Ueland PM, Ebrahim SB.
    Heart; 1999 Oct 15; 82(4):448-54. PubMed ID: 10490559
    [Abstract] [Full Text] [Related]

  • 17. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Boufidou AI, Makedou AD, Adamidis DN, Karvounis HI, Gourassas JT, Kesidis HT, Makedou KG, Papadopoulos CE, Parharidis GE, Louridas GE.
    Curr Med Res Opin; 2004 Oct 15; 20(2):175-80. PubMed ID: 15006011
    [Abstract] [Full Text] [Related]

  • 18. Homocysteine and outcome in young patients with acute coronary syndromes.
    Martín-Herrero F, Martín-Moreiras J, Pabón P, Sánchez PL, Moríñigo-Muñoz JL, Jimenez-Candil J, Cruz-González I, Alberca I, González-Porras JR, Martín-Luengo C.
    Int J Cardiol; 2007 May 31; 118(2):183-8. PubMed ID: 17023077
    [Abstract] [Full Text] [Related]

  • 19. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE.
    N Engl J Med; 1997 Jul 24; 337(4):230-6. PubMed ID: 9227928
    [Abstract] [Full Text] [Related]

  • 20. Serum lipid profiles and homocysteine levels in adults with stroke or myocardial infarction in the town of Gombe in northern Nigeria.
    Glew RH, Okolie H, Crossey M, Suberu O, Trujillo M, Pereyra M, Vanderjagt DJ.
    J Health Popul Nutr; 2004 Dec 24; 22(4):341-7. PubMed ID: 15663167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.